Bastide le Confort Medical (BLC) AI Stock Analysis

• Market Cap: €199.18M
• Dividend Yield: N/A
• Average Volume (3M): 4.71K
• Price to Earnings (P/E): 122.8
• Beta (1Y): 0.68
• Revenue Growth: 3.24%
• EPS Growth: -75.05%
• Country: FR
• Employees: 3,635
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Distribution
• EPS (TTM): 0.23
• Shares Outstanding: 7,361,478
• 10 Day Avg. Volume: 5,929
• 30 Day Avg. Volume: 4,712
• PEG Ratio: 0.40
• Price to Book (P/B): 2.65
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 13.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 63 Neutral
• Price Target: ―

The overall stock score is influenced primarily by a stable technical outlook, with the stock trading above key moving averages. However, financial performance issues such as negative net income and high leverage, combined with a high P/E ratio, suggest potential risks. The absence of earnings call data and corporate events means these factors did not contribute to the score.

Bastide le Confort Medical Business Overview & Revenue Model

Company Description

Bastide Le Confort Médical SA engages in the sale and rental of medical equipment in France. The company offers comfort and health products, such as lift chairs, bathroom and well-being products, pillows and cushions, seats, phones keys, measuring devices, technical aids, fitness products, blood pressure monitors, and pillboxes ; and incontinence products, including absorbent and support briefs, anatomical protections, protections for men and women, disposable mattress pads, PVC panties, and hygiene and body care products. It also provides medical materials comprising home support products wheel chairs, electric scooters, walkers, bed tables and rails, and transfer aids, air mattress, sick lifts, and standers; and medical equipment consisting of consumables, care and dressings, hygiene and disinfection products, outfits and briefcases, and other medical equipment, as well as home support services for elderly, senior, or disabled. It offers its products through approximately 130 stores, as well as through an online store. The company was founded in 1977 and is headquartered in Caissargues, France.

How the Company Makes Money

Bastide le Confort Medical generates revenue through multiple streams including the sale and rental of medical equipment, such as wheelchairs, hospital beds, and respiratory devices. Additionally, the company earns income from providing home healthcare services, which include home-based treatments and support for chronic conditions. BLC also partners with healthcare institutions and insurance companies to supply and manage medical equipment and services, further contributing to its revenue. The company's growth is supported by its strategic acquisitions and expansion into new geographical markets, enhancing its distribution network and service offerings.

Bastide le Confort Medical Financial Statement Overview

Summary

Bastide le Confort Medical shows growth in revenue and operational cash flow, but profitability has been inconsistent with recent net losses. The high leverage and fluctuating free cash flows present financial risks that should be monitored closely.

Income Statement

The company experienced steady revenue growth with a CAGR of approximately 9.5% over the past five years, although the recent year saw a slight decrease in gross profit margin. The net income turned negative in the latest year, indicating profitability challenges that need addressing.

Balance Sheet

The company maintains a high debt-to-equity ratio of 5.12 in 2024, indicating significant leverage which poses risk. However, the equity ratio has been relatively stable, showing some level of balance in the capital structure.

Cash Flow

Free cash flow has been volatile but positive in recent years, with a significant drop from 2023 to 2024. The operating cash flow remains strong relative to net income, although the free cash flow to net income ratio is concerning due to the negative net income.

Breakdown
TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
540.26M	529.75M	508.03M	468.30M	444.07M	382.71M
	Gross Profit
51.59M	46.83M	333.73M	306.80M	280.26M	251.61M
	EBIT
47.20M	44.22M	42.82M	38.93M	37.50M	33.69M
	EBITDA
114.74M	107.20M	82.36M	79.51M	80.19M	66.67M
	Net Income Common Stockholders
1.71M	-900.00K	16.07M	13.68M	13.45M	11.60M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
31.30M	23.62M	36.71M	22.13M	33.74M	35.42M
	Total Assets
675.97M	647.07M	657.08M	632.55M	569.11M	506.00M
	Total Debt
420.68M	408.65M	427.39M	419.23M	357.62M	306.29M
	Net Debt
389.37M	385.03M	390.69M	397.10M	323.88M	270.87M
	Total Liabilities
598.33M	566.34M	568.99M	545.89M	484.05M	426.38M
	Stockholders Equity
76.08M	79.77M	87.65M	84.56M	81.31M	75.67M
Cash Flow		Free Cash Flow
14.98M	10.64M	36.65M	-6.51M	19.62M	-179.00K
	Operating Cash Flow
82.03M	66.04M	90.28M	46.76M	66.13M	39.61M
	Investing Cash Flow
-66.38M	-43.65M	-76.27M	-104.74M	-73.45M	-50.55M
	Financing Cash Flow
-20.72M	-35.55M	7.53M	39.81M	9.65M	25.87M

Bastide le Confort Medical Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 28.95
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:BLC, the sentiment is Positive. The current price of 28.95 is above the 20-day moving average (MA) of 27.75, above the 50-day MA of 26.99, and above the 200-day MA of 23.18, indicating a bullish trend. The MACD of 0.25 indicates Negative momentum. The RSI at 62.63 is Neutral, neither overbought nor oversold. The STOCH value of 73.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:BLC.

Bastide le Confort Medical Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BLC	63 Neutral	€199.18M	122.78	11.71%	―	3.24%	-75.05%
Sector *	54 Neutral	$5.28B	3.29	-45.38%	2.80%	16.77%	-0.08%
0RAF		€292.93M	268.72	1.15%	―	―	―
0OR2		€251.13M	11.25	7.12%	2.50%	―	―
E8TN		€245.63M	62.05	2.27%	―	―	―
61R		€9.84M	―		―	―	―
ABLD		€87.82M	305.08		―	―	―

Bastide le Confort Medical Corporate Events

Bastide Group Releases Semi-Annual Financial Report

The Bastide Group has released its semi-annual financial report for December 31, 2024, making it available to the public and filing it with the Autorité des Marchés Financiers. This report can be accessed on their website, and the next financial update will be the publication of the 3rd quarter 2024-2025 revenue on May 15, 2025. This release underscores Bastide’s commitment to transparency and may impact investor relations and market positioning.

Groupe Bastide Achieves Strong Half-Year Results with Increased Operating Margin

Groupe Bastide reported a positive performance in its 2024-2025 half-year results, with a recurring operating margin increase to 9.1% and a 10.5% rise in operating profit to €22.8 million. The company achieved organic growth of 8.5%, driven by strong performances in home healthcare services, particularly in the respiratory and diabetes sectors. The results reflect the successful implementation of measures to optimize margins and control costs, despite increased financial expenses due to debt refinancing.